Seventure Partners
Edit

Seventure Partners

https://www.seventure.fr
Last activity: 16.09.2026
Active
With over €660m in assets under management as of the end of 2016, Seventure Partners is a leading venture capital firm in Europe. Since 1997, Seventure Partners has invested in innovative businesses with high growth potential in Digital technologies, especially fintech & insurtech, in France and Germany, and in the Life sciences field across Europe, North America ans Asia. Investments can range between €500k and €10m per round, or up to €20m per company, from early to late stage. Seventure is a subsidiary of Natixis Global Asset Management. Natixis is the corporate investment management and financial services arm of Groupe BPCE, the second-largest French bank. For more details: www.seventure.com
Followers
9.92K
News
349
Portfolio
7
Mentions
91
Location: France, Ile-de-France, Paris
Employees: 11-50
Founded date: 1997
Investment Type: Venture Capital
Investment Stage: Series A; Series B; Series C; Series D; Series E; Series F; Series G; Series H

Portfolio 7

DateNameWebsiteTotal RaisedLocation
01.07.2026Wultrawultra.com$10.85MCzech Repu...
15.10.2025Tubulistubulis.com$629.54MGermany
30.09.2024Sequentia ...sequentiabiotech.com$11.19M-
30.03.2023Glopalmerchants.glopal.com$26.26MFrance, Il...
29.03.2023Glopalglopal.com$21.78MMetropolit...
05.05.2021Cytoki Pha...cytokipharma.com$45MDenmark, G...
10.11.2014Humedics G...humedics.eu$7.83MGermany, B...

News 349

DateTitleDescription
06.08.2026Vedanta Biosciences Secures $60 Million in Funding and Strengthens Leadership Team Ahead of Pivotal Phase 3 DataVedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointestinal diseases, today announced securing $60...
23.07.2026Another milestone for Reboat, a French pioneer in sailboat refurbishment: Seventure Partners takes a stake in the company to accelerate its growthReboat announces the closing of a funding round led by Seventure Partners, alongside existing investors and business angels, including Charlotte Souleau, Managing Director for...
21.07.2026Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with progression-free survival in patients with indolent non-Hodgkin lymphoma in the watch-and-wait settingEnterome SA, a clinical-stage company pioneering OncoMimics™, a new class of off-the-shelf, multi-targeted in vivo immune therapies, today announced new positive interim data...
29.06.2026Wultra Raises €6.8 Million in Series A Funding to Accelerate Global Expansion of Post-Quantum Digital Identity SolutionsWultra, a provider of post-quantum authentication and digital identity solutions for banks and fintechs, announced the completion of a €6.8 million Series A funding round....
09.06.2026Infomedia Announces Acquisition of Veact in Europe, Expanding Global Automotive Aftersales EcosystemInfomedia, a global leader in automotive aftersales technology, has completed the acquisition of Veact GmbH, a leading European provider of data activation, predictive service...
28.05.2026Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphomaEnterome SA, a clinical-stage company pioneering OncoMimics™, a new class of off-the-shelf, multi-targeted in vivo immune therapies, today announced that the U.S. Food and...
27.05.2026vorteX-io raises €8.5 million to make hydrological data a driver of national sovereigntyVorteX -io Raises €8.5 Million from Seventure Partners, Banque des Territoires, and Daphni to Turn Hydrological Data into a Lever for National Sovereignty and Address Global...
19.05.2026Social AdTech firm Mediads raises €3 million to accelerate its expansion into the USMediads, a pioneering social adtech company since 2022 specialising in social publishing, which offers a platform designed to boost the performance of
18.05.2026Microbiotica reports positive results for MB097 in advanced melanomaData suggests microbiome co-therapy may help overcome resistance to anti‑PD‑1 treatment. Microbiotica has announced positive findings from its phase 1b MELODY‑1...
12.05.2026Enterome presents Phase 2 indolent non-Hodgkin lymphoma data at EHA showing EO2463 induces B cell target-specific CD8 T-cell expansion correlating with clinical outcomesEnterome SA, a clinical-stage company pioneering OncoMimics™, a new class of off-the-shelf, multi-target in vivo immune therapies shown to induce a rapid, long-lasting and...
Show more

Mentions in press and media 91

DateTitleDescription
16.09.2026Hackuity secures $19M to address rising AI-driven security vulnerabilitiesFrance-based cybersecurity company Hackuity has raised $19 million in funding to further develop its vulnerability management platform and expand internationally. The round was led by Forgepoint Capital International, with participation fro...
28.07.2026Cargill Ventures eyes renewed dealmaking as agrifoodtech resetsAfter two years focusing on managing its existing portfolio, Cargill Ventures is gearing up for renewed activity. The corporate venture arm has recently made two as-yet-unannounced investments—one in a global fund and another in the next-ge...
02.07.2026Post-Quantum Digital Identity Leader Wultra Secures €6.8M for Global ExpansionWultra, a leader in post-quantum digital identity, successfully raised €6.8 million in Series A funding. This significant investment fuels global expansion of its advanced authentication and digital identity solutions. Capital will scale it...
01.07.2026Wultra Raises €6.8 Million in Series A Funding to Accelerate Global Expansion of Post-Quantum Digital Identity SolutionsPRAGUE , July 1, 2026 /PRNewswire/ -- Wultra, a European provider of post-quantum authentication and digital identity solutions for banks and fintechs, announced the completion of a €6.8 million Series A funding round. Following the establi...
30.06.2026Post Quantum Security: Why Startup Wultra Secured €6.8 Million for Digital IdentityWhile the world is still debating the potential of artificial intelligence, experts in the background are already preparing defenses against the threats posed by these and future technologies. The Czech startup Wultra has now raised €6.8 mi...
29.06.2026Wultra Raises €6.8 Million Series A To Expand Post-Quantum Digital Identity SolutionsWultra announced that it has raised €6.8 million in Series A funding to accelerate the global expansion of its post-quantum authentication and digital identity solutions. The round was led by Seventure Partners, with participation from new ...
10.06.2026Physical AI Powerhouse: Neura Robotics Lands $1.4 Billion InvestmentNeura Robotics secured a record $1.4 billion Series C funding. Global tech giants like Amazon, NVIDIA, Qualcomm, and Tether led the investment. This catapults Neura's valuation to $7 billion, achieving unicorn status. The company pioneers c...
10.06.2026Neura Robotics erhält 1,4 MilliardenIm #DealMonitor für den 10. Juni werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-Arc...
19.05.2026Natixis Investment Managers’ Funds Honored at the 2026 LSEG Lipper Fund Awards WorldwideNatixis Investment Managers (Natixis IM) today announced that several of its affiliate asset management companies, including DNCA Investments, Dorval Asset Management, Mirova*, Ostrum Asset Management, Vega Investment Solutions, and WCM Inv...
31.03.2026Standing Ovation nets $34m, gears up for US launch of casein via precision fermentationFrench startup Standing Ovation has raised a €25 million ($28.5 million) Series B round and secured an additional €5 million ($5.7 million) in non-dilutive funding to scale dairy proteins via precision fermentation. The round was jointly le...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In